SummaryThe leading business intelligence provider GBI Research has released its latest research report, entitled Travel Vaccines Market to 2019 Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segmen...
|
$ 3500
|
|
|
The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report ...
|
$ 9500
|
|
|
EpiCast Report: Hepatitis C Virus - Epidemiology Forecast to 2022
Summary
Hepatitis C is a largely asymptomatic liver disease caused by the hepatitis C virus (HCV). HCV is an escalating public health problem and burdens an estimated 3% of the w
|
$ 3995
|
|
|
Hepatitis – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Hepatitis - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hep
|
$ 2000
|
|
|
Hepatitis C – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Hepatitis C - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
$ 2500
|
|
|
This is a professional and depth research report on China Hepatitis B Vaccine industry. This report has firstly introduced Hepatitis B Vaccine definition classification industry chain etc related information. Then introduced Hepatitis B Vaccine ma...
|
$ 2000
|
|
|
Hepatitis D – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Hepatitis D - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
$ 2000
|
|
|
This report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report...
|
$ 8750
|
|
|
The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report ...
|
$ 8750
|
|
|
The report contains 320 pages, 93 tables and presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and et
|
$ 8750
|
|
|
Hepatitis B – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Hepatitis B - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for
|
$ 2000
|
|
|
GBI Research, the leading business intelligence provider, has released its latest research Hepatitis C Therapeutics Market to 2018 - Expected Launch of GS-7977 in 2015 will Pave the Way for an Oral Interferon-free Combination Therapy”, which...
|
$ 3500
|
|
|
TechNavio's analysts forecast the Global Hepatitis Drugs market to grow at a CAGR of 12.42 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in demand for hepatitis drugs in developing...
|
$ 1500
|
|
|
According to the National Serum Epidemiological Survey of Hepatitis B and the Related Diseases, hepatitis B surface antigen carrier rate of 1 to 59 years old group nationwide is 7.18%. Calculated at this data, there are still about 93 million hepatit
|
$ 1900
|
|
|
Hepatitis C – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Hepatitis C - Pipeline Review, H2 2012'', provides an overview of the Hepatitis C therapeutic pipeline. This report provides information on the therapeutic development for
|
$ 2500
|
|
|
Hepatitis – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Hepatitis - Pipeline Review, H2 2012'', provides an overview of the Hepatitis therapeutic pipeline. This report provides information on the therapeutic development for Hepati
|
$ 2500
|
|
|
The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed....
|
$ 8750
|
|
|
This DataPack presents test volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides the 2010-2018 test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc...
|
$ 6900
|
|
|
Hepatitis A Global Clinical Trials Review, H1, 2012
Summary
GlobalData''s clinical trial report, “Hepatitis A Global Clinical Trials Review, H1, 2012" provides data on the Hepatitis A clinical trial scenario. This report provides elemental infor
|
$ 2500
|
|
|
Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019
Summary
GlobalData, the industry analysis specialist, has released its new report, “Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to
|
$ 3995
|
|
|